The Dermatology Life Quality Index (DLQI) as the Primary Outcome in Randomised Clinical Trials: A systematic review

Further Publications Immunology

Heterologous versus homologous COVID-19 booster vaccinations for adults: systematic review with meta-analysis and trial sequential analysis of randomised clinical trials

BMC Med

Asante MA, Michelsen ME, Balakumar MM, Kumburegama B, Sharifan A, Thomsen AR, Korang SK, Gluud C, Menon S

doi: 10.1186/s12916-024-03471-3

Melanoma and Skin Cancer

Patient-reported outcomes in randomized controlled trials evaluating BRAF inhibitors in patients with cutaneous melanoma: a systematic scoping review of quality of reporting and trial results

Melanoma Res

Al-Naesan I, Krepper D, Sparano F, Sztankay M, Efficace F, Giesinger JM

doi: 10.1097/CMR.0000000000001014

Further Publications Rheumatology

Sex-related differences in efficacy and safety outcomes in axial spondyloarthritis randomized clinical trials: A systematic literature review and meta-analysis

Arthritis Care Res (Hoboken)

Gao A, Pardo JP, Dang S, Gensler LS, Mease P, Eder L

doi: 10.1002/acr.25512

Psoriatic Arthritis

The impact of psoriatic arthritis on quality of life: a systematic review

Ther Adv Musculoskelet Dis

James L, Hailey LH, Suribhatla R, McGagh D, Amarnani R, Bundy CE, Kirtley S, O'Sullivan D, Steinkoenig I, White JPE, Vivekanantham A, Coates LC

doi: 10.1177/1759720X241295920

Psoriatic Arthritis

Treatment of early oligoarticular psoriatic arthritis with apremilast: primary outcomes at week 16 from the FOREMOST randomised controlled trial

Ann Rheum Dis

Gossec L, Coates LC, Gladman DD, Aelion JA, Vasandani J, Pinter A, Merola JF, Kavanaugh A, Reddy J, Wang R, Brunori M, Klyachkin Y, Deignan C, Mease PJ

doi: 10.1136/ard-2024-225833

Allergic Diseases

Leukotriene receptor antagonists as add-on therapy to antihistamines for urticaria: a systematic review and meta-analysis of randomized clinical trials

J Allergy Clin Immunol

Rayner DG, Liu M, Chu AWL, Chu X, Guyatt GH, Oykhman P, Cao DJ, Moellman J, Ben-Shoshan M, Baker DR, Waserman S, Lang D, Sheikh J, Mathur SK, Beck LA, Khan DA, Oliver ET, Asiniwasis RN, Cole EF, Wheeler KE, Runyon L, Chan J, Trayes KP, Eftekhari S, Gardner DD, Winders T, Saini SS, Bernstein J, Chu DK

doi: 10.1016/j.jaci.2024.05.026

Rheumatoid Arthritis

Cardiovascular safety of the class of JAK inhibitors or tocilizumab compared with TNF inhibitors in patients with rheumatoid arthritis: Systematic review and a traditional and Bayesian network meta-analysis of randomized clinical trials

Semin Arthritis Rheum

Pugliesi A, Oliveira DGC, Filho VAS, Machado JO, Pereira AG, Bichuette JCS, Sachetto Z, de Carvalho LSF, Bertolo MB

doi: 10.1016/j.semarthrit.2024.152563

Melanoma and Skin Cancer

Adjuvant pembrolizumab versus placebo in resected stage III melanoma (EORTC 1325-MG/KEYNOTE-054): long-term, health-related quality-of-life results from a double-blind, randomised, controlled, phase 3 trial

Lancet Oncol

Bührer E, Kicinski M, Mandala M, Pe M, Long GV, Atkinson V, Blank CU, Haydon A, Dalle S, Khattak A, Carlino MS, Meshcheryakov A, Sandhu S, Puig S, Schadendorf D, Jamal R, Rutkowski P, van den Eertwegh AJM, Coens C, Grebennik D, Krepler C, Robert C, Eggermont AMM

doi: 10.1016/S1470-2045(24)00338-3

Further Publications Immunology

A systematic review and meta-analysis of the response to placebo in clinical trials of inclusion body myositis

Rheumatology (Oxford)

Naddaf E, Skolka MP, Prokop L, Dimachkie MM, Hogrel JY, Benveniste O, Wang Z, Mandrekar J, West CP, Murad MH

doi: 10.1093/rheumatology/keaf146

Related content